Concerns over Chinese firm conducting trial for vaccine against COVID-19 in Cebu City | Inquirer News

Concerns over Chinese firm conducting trial for vaccine against COVID-19 in Cebu City

By: - Reporter / @nestleCDN
/ 06:34 PM October 13, 2021

CEBU CITY—A councilor has raised concerns over the presence of a Chinese firm, which is allegedly conducting a clinical trial for a vaccine against COVID-19 in this city.

According to Councilor David Tumulak, representatives of WestVac Biopharma R&D from Sichuan in China do not have the authority from the city government to hold clinical trials here.

In his privilege speech during the city council session Wednesday, Tumulak urged the Food and Drug Administration, the Department of Health, and the City Health Department to investigate the matter.

ADVERTISEMENT

“We received information that some individuals in Cebu City’s coastal villages underwent a clinical trial and were given a pay whenever they passed the screening,” he said.

FEATURED STORIES

Tumulak expressed fears that the clinical trials would expose residents to danger.

“I have not even heard about this vaccine,” he said.

Based on a vaccination slip he got, Tumulak said some residents were injected with WestVac Biopharma R&D’s vaccine in a Cebu City hospital, which he refused to identify.

lzb
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Cebu City, Chinese firm, concerns, councilor, COVID-19, Regions, vaccine

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.